COGT Cogent Biosciences, Inc.

Formerly Unum Therapeutics Inc., the company is a biotechnology company focused on developing precision therapies for genetically defined diseases.

$7.93
As of 03/05/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA

03/29/2018
19,407,416
464,798
$153,900,809
0.00%
SEC Edgar Online
10-Q
10-K



Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-2.40
1.33
6.65
-52.71%
-264.14%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy